When was INIA Biosciences founded?

INIA Biosciences was founded in 2020 and raised its 1st funding round 4 years after it was founded.

Where is INIA Biosciences located?

INIA Biosciences is headquartered in Boston, United States.

Who is the current CEO of INIA Biosciences?

Shen Ning of INIA Biosciences. They have also founded 1 company.

How many employees does INIA Biosciences have?

As of May 31, 2026, the latest employee count at INIA Biosciences is 5.

Is INIA Biosciences a funded company?

INIA Biosciences is a funded company, having raised an undisclosed amount across 2 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Mar 15, 2024.

When was the latest funding round of INIA Biosciences?

INIA Biosciences' latest funding was a $***** Grant (prize money) round on Feb 24, 2025, with participation from 1 investor. Its primary sector is Immunology. In United States, the Immunology sector has seen $2.72B in funding in 2026 to date.

Where does INIA Biosciences rank among its competitors?

INIA Biosciences ranks 8th amongst 18 active competitors, of which 7 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was Santersus, which secured an undisclosed amount in Dec, 2025.

Who are the top competitors of INIA Biosciences?

INIA Biosciences' top competitors include SetPoint Medical, Cel-Sci and Boomerang Medical. Among them, Santersus secured the most recent funding round in December, 2025.

INIA Biosciences - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of diagnostic devices to treat inflammatory diseases. The company leverages non-invasive ultrasound with novel diagnostic sensing to treat chronic diseases.

Website: www.iniabiosciences.com/
Social

Key Metrics

Founded Year

2020

Location

Boston, United States

Stage

Funding Raised

Latest Funding Round

Grant (prize money), Feb 24, 2025, $*****

Investors

National Science Foundation & 1 more

Ranked

8^th among 18 active competitors

Employee Count

5 as on May 31, 2026

Similar Companies

SetPoint Medical & 19 more

View INIA Biosciences' full profile

INIA Biosciences has raised funding over 2 rounds. Its first funding round was on Mar 15, 2024. Its latest funding round was a Grant (prize money) round on Feb 24, 2025 for $*****. 1 investor participated in its latest round. INIA Biosciences has 2 institutional investors.

Here is the list of recent funding rounds of INIA Biosciences:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 24, 2025	5410184	Grant (prize money)	2176345	8839421	5894869	1507710
Mar 15, 2024	4888113	Grant (prize money)	8370748	8793254	6933183	National Science Foundation

Access funding benchmarks and valuations. Sign up today!

View details of INIA Biosciences's funding rounds and investors

The founders of INIA Biosciences are Dragana Savic and Shen Ning. Shen Ning is the CEO of INIA Biosciences.

Here are the details of INIA Biosciences' key team members:

Dragana Savic: Co-Founder of INIA Biosciences.
Shen Ning: Co-Founder & CEO of INIA Biosciences.

View details of INIA Biosciences's Founder profiles and Board Members

INIA Biosciences' employee count trend

INIA Biosciences has 5 employees as of May 26. Here is INIA Biosciences's employee count trend over the years:

Employee count trend for INIA Biosciences

Uncover INIA Biosciences' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of INIA Biosciences include SetPoint Medical, Cel-Sci and Boomerang Medical. Here is the list of Top 10 competitors of INIA Biosciences, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	SetPoint Medical 2006, Santa Clarita (United States), Series F	Developer of implantable neuromodulation devices for inflammatory diseases	$388M	Norwest, Medtronic & 32 others	64/100
2nd	Cel-Sci 1983, Vienna (United States), Public	Developer of immunotherapy products for the treatment of cancer and infectious diseases	-	Alpha Capital Partners, Midsummer Capital ... & 7 others	53/100
3rd	Boomerang Medical 2021, Mountain View (United States), Series B	Bioelectronic device technology for the treatment of autoimmune diseases	$35M	Arboretum Ventures, Hatteras Venture Partners	52/100
4th	Impulse Biomedical 2018, Cape Town (South Africa), Seed	Developer of a device for adrenaline auto-injection	-	Futuregrowth, Launch Africa & 2 others	44/100
5th	Ablatus Therapeutics 2015, Cambridge (United Kingdom), Deadpooled	Developer of a device for bimodal electric tissue ablation	$5.72M	NVM, Turquoise & 23 others	39/100
6th	RegenLab 2003, Brooklyn (United States), Funding Raised	Provider of medical devices to develop cellular therapies	-	-	38/100
7th	Santersus 2019, Maur (Switzerland), Series A	Developer of blood purification device used in sepsis, autoimmune diseases, cancer and Covid-19	-	Norcliffe Capital, Terumo Medical	38/100
8th	INIA Biosciences 2020, Boston (United States), Funding Raised	Developer of diagnostic devices to treat inflammatory diseases	-	National Science Foundation, BioInnovation Institute ... Read more	37/100
9th	Hippo Dx 2020, Belgium, Series A	Developer of a medical device to provide an automated test that detects allergies	$4.67M	LRM, AllerFund & 1 others	35/100
10th	Labseed 2009, Lausanne (Switzerland), Seed	Developer of technology to suppress capsular contraction	$115K	Venture Kick, Venturelab	28/100